Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 2.000
+0.010 (0.50%)
Dec 8, 2025, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 27.66 billion as of December 8, 2025. Its market cap has decreased by -25.00% in one year.
Market Cap
27.66B
Enterprise Value
26.63B
Revenue
5.28B
Ranking
n/a
PE Ratio
1,662.08
Stock Price
2.00
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 27.66B, an increase of 972.62%. That is a compound annual growth rate of 10.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 27.66B | -14.75% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | 13.33B | -28.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 409.56B |
| WuXi AppTec | 269.53B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.27B |
| Shanghai United Imaging Healthcare | 107.10B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |